{"nctId":"NCT01464190","briefTitle":"A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients","startDateStruct":{"date":"2011-09"},"conditions":["Chronic Kidney Disease Requiring Chronic Dialysis"],"count":659,"armGroups":[{"label":"PA21","type":"EXPERIMENTAL","interventionNames":["Drug: PA21 (2.5 g tablet containing 500 mg iron)"]},{"label":"Sevelamer carbonate","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sevelamer carbonate"]}],"interventions":[{"name":"PA21 (2.5 g tablet containing 500 mg iron)","otherNames":[]},{"name":"Sevelamer carbonate","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who have completed treatment in Protocol PA-CL-05A\n* Written Informed Consent\n\nExclusion Criteria:\n\n* Hyper/hypo calcemia; hyper intact parathyroid hormone (iPTH)\n* Other significant medical conditions\n* Pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline and Levels at Each Time Point for Serum Phosphorus","description":"Endpoint is Week 28 or the latest available measurement after baseline when Week 28 data is missing.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.2","spread":"1.33"},{"groupId":"OG001","value":"-0.1","spread":"1.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.2","spread":"1.38"},{"groupId":"OG001","value":"0.1","spread":"1.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.0","spread":"1.43"},{"groupId":"OG001","value":"0.2","spread":"1.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"1.57"},{"groupId":"OG001","value":"0.2","spread":"1.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.0","spread":"1.46"},{"groupId":"OG001","value":"0.1","spread":"1.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"1.53"},{"groupId":"OG001","value":"0.2","spread":"1.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"1.52"},{"groupId":"OG001","value":"0.2","spread":"1.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"1.62"},{"groupId":"OG001","value":"0.3","spread":"1.79"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline and Levels at Each Time Point for Serum Calcium","description":"Endpoint is Week 28 or the latest available measurement after baseline when Week 28 data is missing.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"12.07"},{"groupId":"OG001","value":"-0.8","spread":"13.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"12.30"},{"groupId":"OG001","value":"1.5","spread":"14.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"12.94"},{"groupId":"OG001","value":"1.9","spread":"13.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"14.04"},{"groupId":"OG001","value":"2.0","spread":"16.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"13.24"},{"groupId":"OG001","value":"1.6","spread":"13.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"13.57"},{"groupId":"OG001","value":"2.2","spread":"15.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"13.52"},{"groupId":"OG001","value":"2.3","spread":"16.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":"13.86"},{"groupId":"OG001","value":"2.9","spread":"16.68"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline and Levels at Each Time Point for Serum Intact Parathyroid Hormone (iPTH)","description":"Endpoint is Week 28 or the latest available measurement after baseline when Week 28 data is missing.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.8","spread":"177.39"},{"groupId":"OG001","value":"25.9","spread":"186.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.6","spread":"204.39"},{"groupId":"OG001","value":"40.8","spread":"201.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.9","spread":"315.81"},{"groupId":"OG001","value":"64.1","spread":"204.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54.5","spread":"352.92"},{"groupId":"OG001","value":"52.3","spread":"210.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.0","spread":"233.13"},{"groupId":"OG001","value":"72.1","spread":"228.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27.7","spread":"271.31"},{"groupId":"OG001","value":"79.6","spread":"253.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.0","spread":"287.19"},{"groupId":"OG001","value":"71.5","spread":"278.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"52.3","spread":"273.14"},{"groupId":"OG001","value":"67.5","spread":"270.06"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":78,"n":391},"commonTop":["Hyperphosphataemia","Hypertension","Diarrhoea","Muscle spasms","Hypotension"]}}}